Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III).
Cannabis
Cannabis Use Disorder
NESARC-III
Substance-Related and Addictive Disorders
Veterans
Journal
The American journal of psychiatry
ISSN: 1535-7228
Titre abrégé: Am J Psychiatry
Pays: United States
ID NLM: 0370512
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
pubmed:
20
8
2021
medline:
29
4
2022
entrez:
19
8
2021
Statut:
ppublish
Résumé
The authors sought to estimate the prevalence of past-12-month and lifetime cannabis use and cannabis use disorder among U.S. veterans; to describe demographic, substance use disorder, and psychiatric disorder correlates of nonmedical cannabis use and cannabis use disorder; and to explore differences in cannabis use and cannabis use disorder prevalence among veterans in states with and without medical marijuana laws. Participants were 3,119 respondents in the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) who identified as U.S. veterans. Weighted prevalences were calculated. Logistic regression analyses tested associations of nonmedical cannabis use and cannabis use disorder with demographic and clinical correlates and examined whether prevalence differed by state legalization status. The prevalences of any past-12-month cannabis use and cannabis use disorder were 7.3% and 1.8%, respectively. Lifetime prevalences were 32.5% and 5.7%, respectively. Past-12-month and lifetime cannabis use disorder prevalence estimates among nonmedical cannabis users were 24.4% and 17.4%, respectively. Sociodemographic correlates of nonmedical cannabis use and use disorder included younger age, male gender, being unmarried, lower income, and residing in a state with medical marijuana laws. Nonmedical cannabis use and use disorder were associated with most psychiatric and substance use disorders examined. Among veterans, the odds of nonmedical cannabis use and use disorder were elevated among vulnerable subgroups, including those with lower income or psychiatric disorders and among survey participants residing in states with medical marijuana laws. The study findings highlight the need for clinical attention (e.g., screening, assessment) and ongoing monitoring among veterans in the context of increasing legalization of cannabis.
Identifiants
pubmed: 34407625
doi: 10.1176/appi.ajp.2021.20081202
pmc: PMC8724447
mid: NIHMS1733244
doi:
Substances chimiques
Hallucinogens
0
Medical Marijuana
0
Ethanol
3K9958V90M
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
26-35Subventions
Organisme : NIDA NIH HHS
ID : R01 DA048860
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
J Addict Med. 2010 Mar;4(1):47-51
pubmed: 21625378
Drug Alcohol Depend. 2018 May 1;186:10-15
pubmed: 29525698
Prim Care Companion CNS Disord. 2019 Jan 17;21(1):
pubmed: 30677266
JAMA Psychiatry. 2017 Jun 1;74(6):579-588
pubmed: 28445557
Am J Med. 2017 Jun;130(6):678-687.e7
pubmed: 28161344
Am J Public Health. 2015 Dec;105(12):2564-9
pubmed: 26474009
Addict Behav. 2017 May;68:18-23
pubmed: 28088054
J Clin Psychiatry. 2015 Sep;76(9):1174-80
pubmed: 26455669
Am J Psychiatry. 2016 Jun 1;173(6):588-99
pubmed: 26940807
Am J Psychiatry. 2020 Jul 1;177(7):611-618
pubmed: 31964162
Drug Alcohol Depend. 2012 Jan 1;120(1-3):22-7
pubmed: 22099393
J Health Econ. 2015 Jul;42:64-80
pubmed: 25863001
Am J Psychiatry. 2018 Jan 1;175(1):47-53
pubmed: 28946762
Lancet Psychiatry. 2016 Oct;3(10):954-964
pubmed: 27592339
Am J Prev Med. 2012 May;42(5):473-80
pubmed: 22516487
Drug Alcohol Depend. 2015 Mar 1;148:40-6
pubmed: 25604321
Psychol Addict Behav. 2015 Sep;29(3):633-8
pubmed: 26415060
Drug Alcohol Depend. 1995 Jul;39(1):37-44
pubmed: 7587973
Drug Alcohol Depend. 2015 Mar 1;148:27-33
pubmed: 25595052
JAMA Psychiatry. 2016 Mar;73(3):292-7
pubmed: 26842658
Psychol Addict Behav. 2016 May;30(3):415-21
pubmed: 27214172
Am J Psychiatry. 2010 Apr;167(4):473-4
pubmed: 20360330
Addict Behav. 2014 Oct;39(10):1414-7
pubmed: 24930048
Psychol Serv. 2012 Nov;9(4):404-416
pubmed: 22564034
Psychol Med. 2006 Oct;36(10):1447-60
pubmed: 16854249
Drug Alcohol Depend. 2015 Jul 1;152:246-56
pubmed: 25939727
Science. 2006 Aug 18;313(5789):979-82
pubmed: 16917066
Compr Psychiatry. 2013 Aug;54(6):589-98
pubmed: 23375264
Transl Issues Psychol Sci. 2018 Mar;4(1):6-20
pubmed: 30003119
Drug Alcohol Depend. 2019 Feb 1;195:13-15
pubmed: 30557813
J Clin Psychiatry. 2005 Jun;66(6):677-85
pubmed: 15960559
Public Health Rep. 2007 Jan-Feb;122(1):93-100
pubmed: 17236614
Aust N Z J Psychiatry. 2012 Dec;46(12):1182-92
pubmed: 22984111
Am J Prev Med. 2012 Nov;43(5):483-9
pubmed: 23079170
JAMA Psychiatry. 2020 Feb 1;77(2):165-171
pubmed: 31722000
Psychol Addict Behav. 2018 May;32(3):277-288
pubmed: 29595297
Lancet. 2009 Oct 17;374(9698):1383-91
pubmed: 19837255
Arch Intern Med. 2000 Nov 27;160(21):3252-7
pubmed: 11088086
Arch Intern Med. 2007 Mar 12;167(5):476-82
pubmed: 17353495
JAMA Psychiatry. 2018 Jul 1;75(7):733-739
pubmed: 29710317
JAMA Psychiatry. 2015 Dec;72(12):1235-42
pubmed: 26502112
Addict Behav. 2018 Jan;76:223-228
pubmed: 28858694
JAMA Psychiatry. 2015 Aug;72(8):757-66
pubmed: 26039070